At the helm of L.A. Care, the nation’s largest public health plan, Martha Santana-Chin oversees the well-being of over 2.2 million people. But for her, this work is not just professional; it is deeply personal. As a child of Mexican immigrants, she and her family relied on Medi-Cal, C
A Strategic Push into Next-Generation Oncology In a decisive move to bolster its cancer treatment portfolio, pharmaceutical giant AbbVie has committed $650 million upfront for the global rights to a promising new drug from Chinese biotech firm RemeGen. The deal, which could eventually reach over $5
The journey of a single vial of a life-saving biologic from its manufacturing facility to a patient's bedside is a meticulously choreographed ballet of science, security, and speed, where any misstep can have profound consequences. In this intricate ecosystem, the role of logistics has evolved
With Congress back in session, the landscape of American health policy is already fraught with tension. To unravel these complex issues, we're joined by Faisal Zain, a leading expert in healthcare policy and technology. His work provides a crucial lens through which to understand the intricate
The once-clear line separating clinical practice from business strategy has effectively dissolved, compelling medical institutions to recognize that the journey to patient care no longer begins with a referral slip but with a search query. In an environment where patients are empowered consumers
The reverberations from Insilico Medicine's blockbuster public offering continue to reshape the investment landscape, cementing the role of artificial intelligence not as a future aspiration for biotechnology, but as its present-day engine of value and innovation. This successful debut on the
The ambitious goal of accumulating a seven-figure nest egg for retirement often seems like an insurmountable challenge, requiring either extraordinary luck or a high-risk appetite that many investors simply do not possess. However, achieving such a milestone is often the result of a disciplined,
A quiet, holiday-shortened trading session on December 24 gave way to a sudden and perplexing after-hours decline for HCA Healthcare, leaving many investors to wonder if the drop was a harbinger of trouble or merely a phantom move in a market devoid of participants. The stock’s placid close near $
A Public Campaign Ignites a Statewide Healthcare Debate In an unprecedented move that shifts the battle over healthcare costs from closed-door negotiations to the public square, Vermont's largest health insurer has launched a direct and unconventional campaign aimed at its most significant and
An unexpectedly virulent influenza strain sweeping across Canada has transformed the nation's public health challenge into a significant financial windfall for a select group of healthcare companies. The intensity of the 2025 flu season has not only exposed vulnerabilities within the national
